{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T00:49:03Z","timestamp":1793148543637,"version":"4.5.0"},"reference-count":77,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,24]],"date-time":"2025-12-24T00:00:00Z","timestamp":1766534400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T00:00:00Z","timestamp":1769472000000},"content-version":"vor","delay-in-days":34,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"DOI":"10.1038\/s41467-025-67690-9","type":"journal-article","created":{"date-parts":[[2025,12,24]],"date-time":"2025-12-24T05:33:56Z","timestamp":1766554436000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["GBP2 condensates promote ferroptosis to sensitize anti-PD-L1 immunotherapy in melanoma"],"prefix":"10.1038","volume":"17","author":[{"given":"Xin","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shilin","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8092-6687","authenticated-orcid":false,"given":"Xianghai","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuntian","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianchun","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6179-0964","authenticated-orcid":false,"given":"Xiaoping","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liping","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haihang","family":"Nie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yumei","family":"Ning","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fei","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9867-8845","authenticated-orcid":false,"given":"Jun","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6803-9807","authenticated-orcid":false,"given":"Yu","family":"Pang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1596-5505","authenticated-orcid":false,"given":"Qiu","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3510-3010","authenticated-orcid":false,"given":"Fan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5622-966X","authenticated-orcid":false,"given":"Haizhou","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,24]]},"reference":[{"key":"67690_CR1","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1038\/s41573-018-0007-y","volume":"18","author":"J Galon","year":"2019","unstructured":"Galon, J. & Bruni, D. Approaches to treat immune hot, altered and cold tumours with combination immunotherapies. Nat. Rev. Drug Discov. 18, 197\u2013218 (2019).","journal-title":"Nat. Rev. Drug Discov."},{"key":"67690_CR2","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1172\/JCI94586","volume":"128","author":"DMS Hossain","year":"2018","unstructured":"Hossain, D. M. S. et al. Dinaciclib induces immunogenic cell death and enhances anti-PD1-mediated tumor suppression. J. Clin. Investig. 128, 644\u2013654 (2018).","journal-title":"J. Clin. Investig."},{"key":"67690_CR3","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1038\/s41575-019-0126-x","volume":"16","author":"K Ganesh","year":"2019","unstructured":"Ganesh, K. et al. Immunotherapy in colorectal cancer: rationale, challenges and potential. Nat. Rev. Gastroenterol. Hepatol. 16, 361\u2013375 (2019).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"67690_CR4","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1016\/j.ccell.2024.03.011","volume":"42","author":"G Lei","year":"2024","unstructured":"Lei, G., Zhuang, L. & Gan, B. The roles of ferroptosis in cancer: tumor suppression, tumor microenvironment, and therapeutic interventions. Cancer Cell 42, 513\u2013534 (2024).","journal-title":"Cancer Cell"},{"key":"67690_CR5","doi-asserted-by":"publisher","first-page":"2401","DOI":"10.1016\/j.cell.2022.06.003","volume":"185","author":"BR Stockwell","year":"2022","unstructured":"Stockwell, B. R. Ferroptosis turns 10: emerging mechanisms, physiological functions, and therapeutic applications. Cell 185, 2401\u20132421 (2022).","journal-title":"Cell"},{"key":"67690_CR6","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1038\/s41586-019-1170-y","volume":"569","author":"W Wang","year":"2019","unstructured":"Wang, W. et al. CD8(+) T cells regulate tumour ferroptosis during cancer immunotherapy. Nature 569, 270\u2013274 (2019).","journal-title":"Nature"},{"key":"67690_CR7","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1038\/s41568-022-00444-7","volume":"22","author":"S Mehta","year":"2022","unstructured":"Mehta, S. & Zhang, J. Liquid-liquid phase separation drives cellular function and dysfunction in cancer. Nat. Rev. Cancer 22, 239\u2013252 (2022).","journal-title":"Nat. Rev. Cancer"},{"key":"67690_CR8","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.ccell.2020.12.003","volume":"39","author":"A Boija","year":"2021","unstructured":"Boija, A., Klein, I. A. & Young, R. A. Biomolecular condensates and cancer. Cancer Cell 39, 174\u2013192 (2021).","journal-title":"Cancer Cell"},{"key":"67690_CR9","doi-asserted-by":"publisher","first-page":"eaaf4382","DOI":"10.1126\/science.aaf4382","volume":"357","author":"Y Shin","year":"2017","unstructured":"Shin, Y. & Brangwynne, C. P. Liquid phase condensation in cell physiology and disease. Science 357, eaaf4382 (2017).","journal-title":"Science"},{"key":"67690_CR10","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1038\/s41577-021-00572-5","volume":"22","author":"Q Xiao","year":"2022","unstructured":"Xiao, Q., McAtee, C. K. & Su, X. Phase separation in immune signalling. Nat. Rev. Immunol. 22, 188\u2013199 (2022).","journal-title":"Nat. Rev. Immunol."},{"key":"67690_CR11","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1016\/j.molcel.2021.01.024","volume":"81","author":"W Zhou","year":"2021","unstructured":"Zhou, W., Mohr, L., Maciejowski, J. & Kranzusch, P. J. cGAS phase separation inhibits TREX1-mediated DNA degradation and enhances cytosolic DNA sensing. Mol. Cell 81, 739\u2013755.e737 (2021).","journal-title":"Mol. Cell"},{"key":"67690_CR12","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1038\/s41586-023-06255-6","volume":"619","author":"T Nakamura","year":"2023","unstructured":"Nakamura, T. et al. Phase separation of FSP1 promotes ferroptosis. Nature 619, 371\u2013377 (2023).","journal-title":"Nature"},{"key":"67690_CR13","doi-asserted-by":"publisher","first-page":"22240","DOI":"10.1021\/acsnano.3c01199","volume":"17","author":"Y Gao","year":"2023","unstructured":"Gao, Y. et al. Long noncoding RNA URB1-antisense RNA 1 (AS1) suppresses sorafenib-induced ferroptosis in hepatocellular carcinoma by driving ferritin phase separation. ACS Nano 17, 22240\u201322258 (2023).","journal-title":"ACS Nano"},{"key":"67690_CR14","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1038\/nrclinonc.2016.25","volume":"13","author":"DN Khalil","year":"2016","unstructured":"Khalil, D. N., Smith, E. L., Brentjens, R. J. & Wolchok, J. D. The future of cancer treatment: immunomodulation, CARs and combination immunotherapy. Nat. Rev. Clin. Oncol. 13, 273\u2013290 (2016).","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"67690_CR15","doi-asserted-by":"publisher","first-page":"17","DOI":"10.2202\/1544-6115.1128","volume":"4","author":"B Zhang","year":"2005","unstructured":"Zhang, B. & Horvath, S. A general framework for weighted gene co-expression network analysis. Stat. Appl. Genet. Mol. Biol. 4, 17 (2005).","journal-title":"Stat. Appl. Genet. Mol. Biol."},{"key":"67690_CR16","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.cell.2014.12.033","volume":"160","author":"MS Rooney","year":"2015","unstructured":"Rooney, M. S., Shukla, S. A., Wu, C. J., Getz, G. & Hacohen, N. Molecular and genetic properties of tumors associated with local immune cytolytic activity. Cell 160, 48\u201361 (2015).","journal-title":"Cell"},{"key":"67690_CR17","doi-asserted-by":"publisher","first-page":"2930","DOI":"10.1172\/JCI91190","volume":"127","author":"M Ayers","year":"2017","unstructured":"Ayers, M. et al. IFN-\u03b3-related mRNA profile predicts clinical response to PD-1 blockade. J. Clin. Investig. 127, 2930\u20132940 (2017).","journal-title":"J. Clin. Investig."},{"key":"67690_CR18","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1016\/j.immuni.2013.10.003","volume":"39","author":"G Bindea","year":"2013","unstructured":"Bindea, G. et al. Spatiotemporal dynamics of intratumoral immune cells reveal the immune landscape in human cancer. Immunity 39, 782\u2013795 (2013).","journal-title":"Immunity"},{"key":"67690_CR19","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/s40425-017-0215-8","volume":"5","author":"P Danaher","year":"2017","unstructured":"Danaher, P. et al. Gene expression markers of tumor infiltrating leukocytes. J. Immunother. Cancer 5, 18 (2017).","journal-title":"J. Immunother. Cancer"},{"key":"67690_CR20","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-50881-1","volume":"15","author":"Y Wee","year":"2024","unstructured":"Wee, Y. et al. Tumour-intrinsic endomembrane trafficking by ARF6 shapes an immunosuppressive microenvironment that drives melanomagenesis and response to checkpoint blockade therapy. Nat. Commun. 15, 6613 (2024).","journal-title":"Nat. Commun."},{"key":"67690_CR21","doi-asserted-by":"crossref","unstructured":"Huang, F. et al. Guanosine triphosphate links MYC-dependent metabolic and ribosome programs in small-cell lung cancer. J. Clin. Investig. 131, e139929 (2021).","DOI":"10.1172\/JCI139929"},{"key":"67690_CR22","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1158\/0008-5472.CAN-22-2145","volume":"83","author":"S Zou","year":"2023","unstructured":"Zou, S. et al. CSN6 mediates nucleotide metabolism to promote tumor development and chemoresistance in colorectal cancer. Cancer Res. 83, 414\u2013427 (2023).","journal-title":"Cancer Res."},{"key":"67690_CR23","doi-asserted-by":"publisher","first-page":"1647","DOI":"10.1001\/jama.294.13.1647","volume":"294","author":"CR Ferrone","year":"2005","unstructured":"Ferrone, C. R. et al. Clinicopathological features of and risk factors for multiple primary melanomas. JAMA 294, 1647\u20131654 (2005).","journal-title":"JAMA"},{"key":"67690_CR24","doi-asserted-by":"publisher","first-page":"402","DOI":"10.3892\/etm.2022.11329","volume":"23","author":"M Gheoca","year":"2022","unstructured":"Gheoca, M. et al. Histopathological evaluation of cutaneous malignant melanoma: a retrospective study. Exp. Ther. Med. 23, 402 (2022).","journal-title":"Exp. Ther. Med."},{"key":"67690_CR25","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1038\/s41586-025-08732-6","volume":"640","author":"S Yuan","year":"2025","unstructured":"Yuan, S. et al. VDAC2 loss elicits tumour destruction and inflammation for cancer therapy. Nature 640, 1062\u20131071 (2025).","journal-title":"Nature"},{"key":"67690_CR26","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1016\/j.ccell.2022.02.003","volume":"40","author":"P Liao","year":"2022","unstructured":"Liao, P. et al. CD8(+) T cells and fatty acids orchestrate tumor ferroptosis and immunity via ACSL4. Cancer Cell 40, 365\u2013378.e366 (2022).","journal-title":"Cancer Cell"},{"key":"67690_CR27","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1038\/nchembio.2239","volume":"13","author":"S Doll","year":"2017","unstructured":"Doll, S. et al. ACSL4 dictates ferroptosis sensitivity by shaping cellular lipid composition. Nat. Chem. Biol. 13, 91\u201398 (2017).","journal-title":"Nat. Chem. Biol."},{"key":"67690_CR28","doi-asserted-by":"publisher","first-page":"2358","DOI":"10.1016\/j.ymthe.2020.08.021","volume":"28","author":"J Liu","year":"2020","unstructured":"Liu, J., Xia, X. & Huang, P. xCT: a critical molecule that links cancer metabolism to redox signaling. Mol. Ther. 28, 2358\u20132366 (2020).","journal-title":"Mol. Ther."},{"key":"67690_CR29","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1038\/s41418-019-0380-z","volume":"27","author":"L Wang","year":"2020","unstructured":"Wang, L. et al. ATF3 promotes erastin-induced ferroptosis by suppressing system Xc. Cell Death Differ. 27, 662\u2013675 (2020).","journal-title":"Cell Death Differ."},{"key":"67690_CR30","doi-asserted-by":"crossref","unstructured":"Zhao, L. et al. Lactate dehydrogenase B noncanonically promotes ferroptosis defense in KRAS-driven lung cancer. Cell Death Differ. 32, 632\u2013645 (2025).","DOI":"10.1038\/s41418-024-01427-x"},{"key":"67690_CR31","doi-asserted-by":"publisher","first-page":"e41090","DOI":"10.7554\/eLife.41090","volume":"7","author":"RS Gejman","year":"2018","unstructured":"Gejman, R. S. et al. Rejection of immunogenic tumor clones is limited by clonal fraction. Elife 7, e41090 (2018).","journal-title":"Elife"},{"key":"67690_CR32","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1016\/j.cell.2020.09.048","volume":"183","author":"Z Liu","year":"2020","unstructured":"Liu, Z. et al. Detecting tumor antigen-specific T cells via interaction-dependent fucosyl-biotinylation. Cell 183, 1117\u20131133.e1119 (2020).","journal-title":"Cell"},{"key":"67690_CR33","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1038\/s43018-023-00522-1","volume":"4","author":"Y Wu","year":"2023","unstructured":"Wu, Y. et al. Disrupting the phase separation of KAT8-IRF1 diminishes PD-L1 expression and promotes antitumor immunity. Nat. Cancer 4, 382\u2013400 (2023).","journal-title":"Nat. Cancer"},{"key":"67690_CR34","doi-asserted-by":"publisher","first-page":"1216","DOI":"10.1016\/j.molcel.2021.01.010","volume":"81","author":"M Yu","year":"2021","unstructured":"Yu, M. et al. Interferon-\u03b3 induces tumor resistance to anti-PD-1 immunotherapy by promoting YAP phase separation. Mol. Cell 81, 1216\u20131230.e1219 (2021).","journal-title":"Mol. Cell"},{"key":"67690_CR35","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1142\/S0219720005000886","volume":"3","author":"K Peng","year":"2005","unstructured":"Peng, K. et al. Optimizing long intrinsic disorder predictors with protein evolutionary information. J. Bioinform. Comput. Biol. 3, 35\u201360 (2005).","journal-title":"J. Bioinform. Comput. Biol."},{"key":"67690_CR36","doi-asserted-by":"publisher","first-page":"5559","DOI":"10.1016\/j.cell.2021.10.001","volume":"184","author":"Q Liu","year":"2021","unstructured":"Liu, Q. et al. Glycogen accumulation and phase separation drives liver tumor initiation. Cell 184, 5559\u20135576.e5519 (2021).","journal-title":"Cell"},{"key":"67690_CR37","doi-asserted-by":"publisher","first-page":"1578","DOI":"10.1038\/s41556-019-0433-z","volume":"21","author":"D Cai","year":"2019","unstructured":"Cai, D. et al. Phase separation of YAP reorganizes genome topology for long-term YAP target gene expression. Nat. Cell Biol. 21, 1578\u20131589 (2019).","journal-title":"Nat. Cell Biol."},{"key":"67690_CR38","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.devcel.2023.11.020","volume":"59","author":"M Xiao","year":"2024","unstructured":"Xiao, M. et al. Smad4 sequestered in SFPQ condensates prevents TGF-\u03b2 tumor-suppressive signaling. Dev. Cell 59, 48\u201363.e48 (2024).","journal-title":"Dev. Cell"},{"key":"67690_CR39","doi-asserted-by":"publisher","first-page":"2262","DOI":"10.1158\/0008-5472.CAN-22-3009","volume":"83","author":"F Ye","year":"2023","unstructured":"Ye, F. et al. TGF\u03b2 antagonizes IFN\u03b3-mediated adaptive immune evasion via activation of the AKT-Smad3-SHP1 axis in lung adenocarcinoma. Cancer Res. 83, 2262\u20132277 (2023).","journal-title":"Cancer Res."},{"key":"67690_CR40","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1038\/s41586-023-06299-8","volume":"620","author":"C Guo","year":"2023","unstructured":"Guo, C. et al. SLC38A2 and glutamine signalling in cDC1s dictate anti-tumour immunity. Nature 620, 200\u2013208 (2023).","journal-title":"Nature"},{"key":"67690_CR41","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2022.121724","volume":"288","author":"Y Yu","year":"2022","unstructured":"Yu, Y. et al. Iron-based nanoscale coordination polymers synergistically induce immunogenic ferroptosis by blocking dihydrofolate reductase for cancer immunotherapy. Biomaterials 288, 121724 (2022).","journal-title":"Biomaterials"},{"key":"67690_CR42","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202201734","volume":"9","author":"Z Li","year":"2022","unstructured":"Li, Z. et al. Immunogenic cell death activates the tumor immune microenvironment to boost the immunotherapy efficiency. Adv. Sci. 9, e2201734 (2022).","journal-title":"Adv. Sci."},{"key":"67690_CR43","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.1038\/s41591-018-0157-9","volume":"24","author":"N Auslander","year":"2018","unstructured":"Auslander, N. et al. Robust prediction of response to immune checkpoint blockade therapy in metastatic melanoma. Nat. Med. 24, 1545\u20131549 (2018).","journal-title":"Nat. Med."},{"key":"67690_CR44","doi-asserted-by":"publisher","first-page":"eaar3593","DOI":"10.1126\/science.aar3593","volume":"362","author":"R Cristescu","year":"2018","unstructured":"Cristescu, R. et al. Pan-tumor genomic biomarkers for PD-1 checkpoint blockade-based immunotherapy. Science 362, eaar3593 (2018).","journal-title":"Science"},{"key":"67690_CR45","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.cell.2016.02.065","volume":"165","author":"W Hugo","year":"2016","unstructured":"Hugo, W. et al. Genomic and transcriptomic features of response to Anti-PD-1 therapy in metastatic melanoma. Cell 165, 35\u201344 (2016).","journal-title":"Cell"},{"key":"67690_CR46","doi-asserted-by":"publisher","first-page":"eaah3560","DOI":"10.1126\/scitranslmed.aah3560","volume":"9","author":"W Roh","year":"2017","unstructured":"Roh, W. et al. Integrated molecular analysis of tumor biopsies on sequential CTLA-4 and PD-1 blockade reveals markers of response and resistance. Sci. Transl. Med. 9, eaah3560 (2017).","journal-title":"Sci. Transl. Med."},{"key":"67690_CR47","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1038\/nature25501","volume":"554","author":"S Mariathasan","year":"2018","unstructured":"Mariathasan, S. et al. TGF\u03b2 attenuates tumour response to PD-L1 blockade by contributing to exclusion of T cells. Nature 554, 544\u2013548 (2018).","journal-title":"Nature"},{"key":"67690_CR48","doi-asserted-by":"publisher","first-page":"1550","DOI":"10.1038\/s12276-020-00493-8","volume":"52","author":"JW Cho","year":"2020","unstructured":"Cho, J. W. et al. Genome-wide identification of differentially methylated promoters and enhancers associated with response to anti-PD-1 therapy in non-small cell lung cancer. Exp. Mol. Med. 52, 1550\u20131563 (2020).","journal-title":"Exp. Mol. Med."},{"key":"67690_CR49","doi-asserted-by":"publisher","first-page":"2032","DOI":"10.1016\/j.ccell.2024.10.010","volume":"42","author":"H Lin","year":"2024","unstructured":"Lin, H. et al. Itaconate transporter SLC13A3 impairs tumor immunity via endowing ferroptosis resistance. Cancer Cell 42, 2032\u20132044.e6 (2024).","journal-title":"Cancer Cell"},{"key":"67690_CR50","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1038\/s41568-023-00557-7","volume":"23","author":"NJ Mullen","year":"2023","unstructured":"Mullen, N. J. & Singh, P. K. Nucleotide metabolism: a pan-cancer metabolic dependency. Nat. Rev. Cancer 23, 275\u2013294 (2023).","journal-title":"Nat. Rev. Cancer"},{"key":"67690_CR51","doi-asserted-by":"publisher","first-page":"4153","DOI":"10.2147\/JIR.S401430","volume":"16","author":"Q Tong","year":"2023","unstructured":"Tong, Q., Li, D., Yin, Y., Cheng, L. & Ouyang, S. GBP5 expression predicted prognosis of immune checkpoint inhibitors in small cell lung cancer and correlated with tumor immune microenvironment. J. Inflamm. Res. 16, 4153\u20134164 (2023).","journal-title":"J. Inflamm. Res."},{"key":"67690_CR52","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1007\/s00262-024-03786-3","volume":"73","author":"Y Tasiheng","year":"2024","unstructured":"Tasiheng, Y. et al. DNA hypo-methylation and expression of GBP4 induces T cell exhaustion in pancreatic cancer. Cancer Immunol. Immunother. 73, 208 (2024).","journal-title":"Cancer Immunol. Immunother."},{"key":"67690_CR53","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1038\/s41556-021-00672-3","volume":"23","author":"G Li","year":"2021","unstructured":"Li, G. et al. LIMIT is an immunogenic lncRNA in cancer immunity and immunotherapy. Nat. Cell Biol. 23, 526\u2013537 (2021).","journal-title":"Nat. Cell Biol."},{"key":"67690_CR54","doi-asserted-by":"publisher","first-page":"1082","DOI":"10.1002\/mc.23447","volume":"61","author":"Y Tian","year":"2022","unstructured":"Tian, Y. et al. GBP2 serves as a novel prognostic biomarker and potential immune microenvironment indicator in renal cell carcinoma. Mol. Carcinog. 61, 1082\u20131098 (2022).","journal-title":"Mol. Carcinog."},{"key":"67690_CR55","doi-asserted-by":"publisher","first-page":"5042","DOI":"10.1038\/s41388-020-1348-7","volume":"39","author":"S Yu","year":"2020","unstructured":"Yu, S. et al. GBP2 enhances glioblastoma invasion through Stat3\/fibronectin pathway. Oncogene 39, 5042\u20135055 (2020).","journal-title":"Oncogene"},{"key":"67690_CR56","doi-asserted-by":"crossref","unstructured":"Wang, H. et al. Subtyping of microsatellite stability colorectal cancer reveals guanylate binding protein 2 (GBP2) as a potential immunotherapeutic target. J. Immunother. Cancer 10, e004302 (2022).","DOI":"10.1136\/jitc-2021-004302"},{"key":"67690_CR57","doi-asserted-by":"publisher","first-page":"2148","DOI":"10.1016\/j.molcel.2021.02.038","volume":"81","author":"W Zhang","year":"2021","unstructured":"Zhang, W. et al. Targeting KDM4A epigenetically activates tumor-cell-intrinsic immunity by inducing DNA replication stress. Mol. Cell 81, 2148\u20132165.e2149 (2021).","journal-title":"Mol. Cell"},{"key":"67690_CR58","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.adg3049","volume":"15","author":"J Li","year":"2023","unstructured":"Li, J. et al. Tumor-specific GPX4 degradation enhances ferroptosis-initiated antitumor immune response in mouse models of pancreatic cancer. Sci. Transl. Med. 15, eadg3049 (2023).","journal-title":"Sci. Transl. Med."},{"key":"67690_CR59","doi-asserted-by":"publisher","DOI":"10.1186\/s13148-020-0807-x","volume":"12","author":"Y Peng","year":"2020","unstructured":"Peng, Y., Wu, Q., Wang, L., Wang, H. & Yin, F. A DNA methylation signature to improve survival prediction of gastric cancer. Clin. Epigenetics 12, 15 (2020).","journal-title":"Clin. Epigenetics"},{"key":"67690_CR60","doi-asserted-by":"publisher","first-page":"1426","DOI":"10.1038\/s41423-024-01230-1","volume":"21","author":"X Liu","year":"2024","unstructured":"Liu, X. et al. Kynurenine-AhR reduces T-cell infiltration and induces a delayed T-cell immune response by suppressing the STAT1-CXCL9\/CXCL10 axis in tuberculosis. Cell Mol. Immunol. 21, 1426\u20131440 (2024).","journal-title":"Cell Mol. Immunol."},{"key":"67690_CR61","doi-asserted-by":"publisher","first-page":"12297","DOI":"10.18632\/oncotarget.3655","volume":"6","author":"H Cirenajwis","year":"2015","unstructured":"Cirenajwis, H. et al. Molecular stratification of metastatic melanoma using gene expression profiling: prediction of survival outcome and benefit from molecular targeted therapy. Oncotarget 6, 12297\u201312309 (2015).","journal-title":"Oncotarget"},{"key":"67690_CR62","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1158\/1541-7786.MCR-07-0344","volume":"6","author":"L Xu","year":"2008","unstructured":"Xu, L. et al. Gene expression changes in an animal melanoma model correlate with aggressiveness of human melanoma metastases. Mol. Cancer Res. 6, 760\u2013769 (2008).","journal-title":"Mol. Cancer Res."},{"key":"67690_CR63","doi-asserted-by":"publisher","first-page":"60940","DOI":"10.18632\/oncotarget.10902","volume":"7","author":"T Budden","year":"2016","unstructured":"Budden, T. et al. Repair of UVB-induced DNA damage is reduced in melanoma due to low XPC and global genome repair. Oncotarget 7, 60940\u201360953 (2016).","journal-title":"Oncotarget"},{"key":"67690_CR64","doi-asserted-by":"publisher","first-page":"7234","DOI":"10.1158\/1078-0432.CCR-05-0683","volume":"11","author":"D Talantov","year":"2005","unstructured":"Talantov, D. et al. Novel genes associated with malignant melanoma but not benign melanocytic lesions. Clin. Cancer Res. 11, 7234\u20137242 (2005).","journal-title":"Clin. Cancer Res."},{"key":"67690_CR65","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1016\/j.cell.2018.09.006","volume":"175","author":"L Jerby-Arnon","year":"2018","unstructured":"Jerby-Arnon, L. et al. A cancer cell program promotes T cell exclusion and resistance to checkpoint blockade. Cell 175, 984\u2013997.e924 (2018).","journal-title":"Cell"},{"key":"67690_CR66","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1016\/j.ccell.2019.01.003","volume":"35","author":"TN Gide","year":"2019","unstructured":"Gide, T. N. et al. Distinct immune cell populations define response to Anti-PD-1 monotherapy and anti-PD-1\/anti-CTLA-4 combined therapy. Cancer Cell 35, 238\u2013255.e236 (2019).","journal-title":"Cancer Cell"},{"key":"67690_CR67","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/j.gpb.2022.08.004","volume":"21","author":"Z Chen","year":"2023","unstructured":"Chen, Z. et al. TIGER: A Web Portal of Tumor Immunotherapy Gene Expression Resource. Genomics Proteomics Bioinformatics.\u00a021, 337\u2013348 (2023).","journal-title":"Genomics Proteomics Bioinformatics."},{"key":"67690_CR68","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/j.celrep.2016.12.019","volume":"18","author":"P Charoentong","year":"2017","unstructured":"Charoentong, P. et al. Pan-cancer immunogenomic analyses reveal genotype-immunophenotype relationships and predictors of response to checkpoint blockade. Cell Rep. 18, 248\u2013262 (2017).","journal-title":"Cell Rep."},{"key":"67690_CR69","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2105-14-7","volume":"14","author":"S H\u00e4nzelmann","year":"2013","unstructured":"H\u00e4nzelmann, S., Castelo, R. & Guinney, J. GSVA: gene set variation analysis for microarray and RNA-seq data. BMC Bioinform. 14, 7 (2013).","journal-title":"BMC Bioinform."},{"key":"67690_CR70","doi-asserted-by":"publisher","first-page":"e1195","DOI":"10.1371\/journal.pone.0001195","volume":"2","author":"Y Hoshida","year":"2007","unstructured":"Hoshida, Y., Brunet, J. P., Tamayo, P., Golub, T. R. & Mesirov, J. P. Subclass mapping: identifying common subtypes in independent disease data sets. PLoS ONE 2, e1195 (2007).","journal-title":"PLoS ONE"},{"key":"67690_CR71","doi-asserted-by":"publisher","first-page":"1210","DOI":"10.1158\/0008-5472.CAN-23-2650","volume":"84","author":"J Shi","year":"2024","unstructured":"Shi, J. et al. The web-based portal SpatialTME integrates histological images with single-cell and spatial transcriptomics to explore the tumor microenvironment. Cancer Res. 84, 1210\u20131220 (2024).","journal-title":"Cancer Res."},{"key":"67690_CR72","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1016\/j.jhep.2023.01.011","volume":"78","author":"Y Liu","year":"2023","unstructured":"Liu, Y. et al. Identification of a tumour immune barrier in the HCC microenvironment that determines the efficacy of immunotherapy. J. Hepatol. 78, 770\u2013782 (2023).","journal-title":"J. Hepatol."},{"key":"67690_CR73","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1038\/nprot.2008.211","volume":"4","author":"W Huang da","year":"2009","unstructured":"Huang da, W., Sherman, B. T. & Lempicki, R. A. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat. Protoc. 4, 44\u201357 (2009).","journal-title":"Nat. Protoc."},{"key":"67690_CR74","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1093\/bioinformatics\/btg405","volume":"20","author":"L Gautier","year":"2004","unstructured":"Gautier, L., Cope, L., Bolstad, B. M. & Irizarry, R. A. affy-analysis of Affymetrix GeneChip data at the probe level. Bioinformatics 20, 307\u2013315 (2004).","journal-title":"Bioinformatics"},{"key":"67690_CR75","doi-asserted-by":"publisher","first-page":"e1000117","DOI":"10.1371\/journal.pcbi.1000117","volume":"4","author":"S Horvath","year":"2008","unstructured":"Horvath, S. & Dong, J. Geometric interpretation of gene coexpression network analysis. PLoS Comput. Biol. 4, e1000117 (2008).","journal-title":"PLoS Comput. Biol."},{"key":"67690_CR76","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2105-8-22","volume":"8","author":"AM Yip","year":"2007","unstructured":"Yip, A. M. & Horvath, S. Gene network interconnectedness and the generalized topological overlap measure. BMC Bioinform. 8, 22 (2007).","journal-title":"BMC Bioinform."},{"key":"67690_CR77","doi-asserted-by":"publisher","first-page":"1551","DOI":"10.1126\/science.1073374","volume":"297","author":"E Ravasz","year":"2002","unstructured":"Ravasz, E., Somera, A. L., Mongru, D. A., Oltvai, Z. N. & Barab\u00e1si, A. L. Hierarchical organization of modularity in metabolic networks. Science 297, 1551\u20131555 (2002).","journal-title":"Science"}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-67690-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-67690-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-67690-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T10:03:52Z","timestamp":1769508232000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-67690-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,24]]},"references-count":77,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["67690"],"URL":"https:\/\/doi.org\/10.1038\/s41467-025-67690-9","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,24]]},"assertion":[{"value":"29 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"964"}}